Your Gateway to European Biotech Innovation

02 - 04 September, 2025

Hotel Arts, Barcelona, Spain

Super Early Bird Passes - SOLD OUT
Early Bird Passes Available

Limited to 500 places, apply to attend before May 30th to save up to £1,000 per ticket

 

Apply Now - Limited Tickets Available

500
Attendees
30+
Countries
50+
Speakers
170+
Therapeutic Developers

 


 

Curated. Connected. Designed for Impact.

Now in its 5th year, Advanced Therapies Europe 2025 is an intentionally intimate event — limited to just 500 senior-level decision-makers — to ensure every conversation drives outcomes. Held in Barcelona, at the heart of Europe’s fast-growing biotech ecosystem, this is where strategic connections ignite progress and insights lead to action. Whether you're here to invest, scale, partner, or launch, ATE 2025 gives you the platform to make it happen.

 

Sponsor With Us Secure Your Place

Meet the speakers

Event Accreditation

Advanced Therapies Europe 2025 has been officially accredited by The CPD Group, the UK’s largest and most trusted continuing professional development accreditation body. This recognition reflects the exceptional educational value of our agenda, speakers, and scientific content.

By attending ATE, you’ll not only gain access to high-level insights from across the advanced therapies landscape — you'll also be able to:

  • Earn CPD credits recognised by employers and professional bodies
  • Receive a certificate of attendance at no additional cost
  • Demonstrate your ongoing commitment to industry excellence

Whether you're attending to stay ahead of regulatory changes, deepen your scientific understanding, or expand your commercial skillset, your time at ATE counts toward your professional growth.

Learn More

CPD Accrediation

Apply to Attend – Only 500 Passes Available

Attendance at Advanced Therapies Europe 2025 is limited to just 500 qualified delegates. Whether you're driving investment, scaling manufacturing, or building your next therapeutic breakthrough, your experience will be tailored, targeted, and designed for maximum impact.

Super Early Bird​​​​​​​ - SOLD OUT!

Early Bird pricing ends 30 May
 — apply now to secure your place at Europe’s premier cell and gene therapy event.

General Admission

This ticket is strictly for therapeutic developers, pharma, gov/regulators, academics, start-ups, and non-profits.

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included
  • VIP Benefits

Industry Admission

This ticket best for CDMOs, CROs, service providers, consultants, and solution providers supporting the advanced therapies sector.

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included
  • VIP Benefits

 

  • Thanks so much for an amazing networking opportunity. I had some great meetings with potential partners.
    Lynn Ficher
    Kmak Capital

Meet our Event Partners

Download the 2024 attendee list

Take a sneak peek at who joined us in 2024

Download the 2024 Attendee List